BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Central Standard Time BEGIN:STANDARD DTSTART:20231102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Central Standard Time TZOFFSETFROM:-0500 TZOFFSETTO:-0600 END:STANDARD BEGIN:DAYLIGHT DTSTART:20230301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Central Daylight Time TZOFFSETFROM:-0600 TZOFFSETTO:-0500 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Introduction - Rade Tomic\, MDUnderstanding the Antibodies: Con nective Tissue Disease with Associated ILD - \;Erin Wilfong \,MD\, PhD Rare ILDs: Pleuroparenchymal fibroelastosis (PPFE)\, Combined Pulmonary Fi brosis and Emphysema (CPFE)\, and Smoking-Related ILDs - Vincent Cottin\, MD\, PhDPatient Reported Outcome Measures - Integrating These in Research and Clinical Practice \;- Alyson Wong\, MDLive Panel Discussion/Audien ce Q&\;A \;- \;Erin Wilfong \,MD\, PhD\; Vincent Cottin\, MD\, PhD\; Alyson Wong\, MD\; Rade Tomic\, MD DTEND:20211110T210000Z DTSTAMP:20240328T154117Z DTSTART:20211110T193000Z LOCATION: SEQUENCE:0 SUMMARY:Expanding Our Clinical Understanding of ILD UID:RFCALITEM638472192778485331 X-ALT-DESC;FMTTYPE=text/html: